Synergistic Molecular Imaging and Therapy System
Legal Citation
Summary of the Inventive Concept
A novel system integrating multivalent molecular imaging and/or therapy with AI, IoT, and blockchain technologies to enable real-time monitoring and personalized treatment.
Background and Problem Solved
The original patent disclosed a multivalent molecular imaging and/or targeted drug delivery method, but it lacked real-time monitoring and tracking capabilities. The new inventive concept addresses this limitation by incorporating AI, IoT, and blockchain technologies to provide a more comprehensive and efficient system.
Detailed Description of the Inventive Concept
The system comprises a multivalent molecule with multiple targeting moieties, each binding to a distinct biomarker. The molecule is integrated with an IoT-enabled device for real-time monitoring of its interaction with the biomarkers. A blockchain-based tracking module ensures secure and transparent data storage and sharing. AI-powered computational models analyze the molecule's interaction with the biomarkers and predict optimal spacer lengths for personalized treatment. The system enables real-time monitoring, personalized treatment, and improved patient outcomes.
Novelty and Inventive Step
The new claims introduce the integration of AI, IoT, and blockchain technologies with the original multivalent molecular imaging and/or therapy concept, providing a novel and non-obvious solution for real-time monitoring and personalized treatment.
Alternative Embodiments and Variations
Alternative embodiments include using different AI algorithms, IoT devices, or blockchain platforms. Variations may include integrating the system with other medical devices or using different types of biomarkers.
Potential Commercial Applications and Market
The Synergistic Molecular Imaging and Therapy System has significant commercial potential in the healthcare industry, particularly in the fields of cancer treatment, personalized medicine, and medical imaging. The system's real-time monitoring and tracking capabilities make it an attractive solution for hospitals, research institutions, and pharmaceutical companies.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K51/082 |
| A | A61 | A61K9/51 |
| A | A61 | A61K47/6893 |
| A | A61 | A61K51/1027 |
| C | C07 | C07D255/02 |
| C | C07 | C07D257/02 |
| C | C07 | C07K7/06 |
| C | C07 | C07K7/64 |
| C | C07 | C07K16/30 |
| G | G01 | G01N33/5008 |
| G | G01 | G01N33/60 |
| C | C07 | C07K2319/00 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Molecular imaging, targeted therapy, radiopharmaceuticals, and biomedical engineering, with expertise in peptide-based molecular targeting, chelation chemistry, and advanced diagnostic/therapeutic technologies
Person of Ordinary Skill (PHOSITA) Profile
A PhD-level researcher with advanced training in biochemistry, molecular biology, and medical imaging technologies, possessing comprehensive knowledge of multivalent molecular design, radioisotope labeling, and emerging medical technologies
Obviousness Rationale
A PHOSITA would recognize that integrating AI, IoT, and blockchain technologies with existing multivalent molecular imaging techniques represents a predictable extension of known medical monitoring and personalization strategies. The core molecular design from the source patent provides a foundational platform for technological augmentation. The proposed system leverages standard computational and tracking technologies to enhance the existing molecular imaging approach in a manner that would be apparent to a skilled practitioner.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,648 |
|---|---|
| Title | Dimerization strategies and compounds for molecular imaging and/or radioimmunotherapy |
| Assignee(s) | UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION |